Genetic diversity of antigens Rv2945c and Rv0309 in Mycobacterium tuberculosis strains may reflect ongoing immune evasion

FEMS Microbiology Letters

Volumn 347, Issue 1, 2013, Pages 77-82

  Jiang, Yi ^a,b   Dou, Xiangfeng ^a   Zhang, Wen ^a,b   Liu, Haican ^a   Zhao, Xiuqin ^a,b   Wang, Haiyin ^a,b   Lian, Lulu ^a   Yu, Qin ^a   Zhang, Jingrui ^a   Li, Guilian ^a,b   Chen, Chen ^a,b   Wan, Kanglin ^a,b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Host pathogen co evolution; Mycobacterium tuberculosis; T cell epitopes

Indexed keywords

AMINO ACID SUBSTITUTION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; GENE SEQUENCE; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNITY; LETTER; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RV0309 GENE; RV2945C GENE; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

MYCOBACTERIUM TUBERCULOSIS;

HOST-PATHOGEN CO-EVOLUTION; MYCOBACTERIUM TUBERCULOSIS; T-CELL EPITOPES;

AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; EPITOPES, T-LYMPHOCYTE; GENETIC VARIATION; HUMANS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; POLYMERASE CHAIN REACTION; TUBERCULOSIS;

EID: 84883822677     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/1574-6968.12222     Document Type: Letter

References (15)

1. Andersen P (1997) Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 45: 115-131.
2. Brunham RC, Plummer FA & Stephens RS (1993) Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun 61: 2273-2276.
3. Comas I, Chakravartti J, Small PM et al. (2010) Human T-cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 42: 498-503.
4. Dawkins R & Krebs JR (1979) Arms races between and within species. Proc R Soc Lond B Biol Sci 205: 489-511.
5. Donald PR & van Helden PD (2009) The global burden of tuberculosis - combating drug resistance in difficult times. N Engl J Med 360: 2393-2395.
6. Dong H, Liu Z, Lv B, Zhang Y, Liu J, Zhao X & Wan K (2010) Spoligotypes of Mycobacterium tuberculosis from different Provinces of China. J Clin Microbiol 48: 4102-4106.
7. Ernst JD, Lewinsohn DM, Behar S, Blythe M, Schlesinger LS, Kornfeld H & Sette A (2008) Meeting report: NIH workshop on the tuberculosis immune epitope database. Tuberculosis (Edinb) 88: 366-370.
8. Farci P, Shimoda A, Coiana A et al. (2000) The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288: 339-344.
9. Harboe M & Wiker HG (1998) Secreted proteins of Mycobacterium leprae. Scand J Immunol 48: 577-584.
10. Jeffares DC, Pain A, Berry A et al. (2007) Genome variation and evolution of the malaria parasite Plasmodium falciparum. Nat Genet 39: 120-125.
11. Kawashima Y, Pfafferott K, Frater J et al. (2009) Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641-645.
12. Mustafa AS (2001) Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. Curr Pharm Biotechnol 2: 157-173.
13. Mustafa AS (2002) Development of new vaccines and diagnostic reagents against tuberculosis. Mol Immunol 39: 113-119.
14. Urwin R, Russell JE, Thompson EA, Holmes EC, Feavers IM & Maiden MC (2004) Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun 72: 5955-5962.
15. Young DB, Kaufmann SH, Hermans PW & Thole JE (1992) Mycobacterial protein antigens: a compilation. Mol Microbiol 6: 133-145.